Psychosocial interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood

A Huertas-Ceballos1, S Logan, C Bennett

  • 1EGA Hospital, Neonatal Unit, UCLH, Huntley Street, London, UK WC1E 6DH. Angela.Huertas-Ceballos@uclh.nhs.uk

Insights

Cognitive behavioral therapy shows promise for treating recurrent abdominal pain in children. While trials were small, results suggest it

Area of Science:

  • Pediatric Gastroenterology
  • Child Psychology
  • Evidence-Based Medicine

Background:

  • Recurrent abdominal pain (RAP) affects 4-25% of school-age children, often without identifiable organic causes.
  • Psychosocial interventions, including cognitive behavioral therapy, are recommended for managing RAP in children.

Purpose of the Study:

  • To evaluate the effectiveness of psychosocial interventions for recurrent abdominal pain or irritable bowel syndrome (IBS) in school-age children.

Main Methods:

  • Comprehensive literature search across multiple databases (CENTRAL, MEDLINE, EMBASE, etc.) from inception to December 2006.
  • Inclusion of randomized trials comparing psychosocial treatments to standard care or waitlists in children meeting RAP or Rome II criteria.
  • Independent screening, data extraction, and analysis using RevMan 4.2.10.

Main Results:

  • Six randomized trials with 167 participants investigated cognitive behavioral interventions.
  • Five studies demonstrated statistically significant pain reduction in children receiving cognitive behavioral therapy compared to control groups.
  • One trial had insufficient data for interpretable results due to a mixed patient group.

Conclusions:

  • Despite small sample sizes and methodological weaknesses in the included trials, consistent evidence suggests cognitive behavioral therapy may be beneficial for childhood RAP.
  • Cognitive behavioral therapy offers a potentially useful intervention for recurrent abdominal pain in children.
  • Most children with RAP, especially in primary care, may improve with reassurance and time.
Abstract

Related Concept Videos

Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...